Listar VHIO - Articles científics por título
Mostrando ítems 98-117 de 861
-
B Cells in Breast Cancer Pathology
(MDPI, 2023-02-28) -
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
(Frontiers Media, 2022-10-03) -
Back-to-back discovery, co-precision, and prevention
(Oxford University Press, 2020-04) -
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population
(Oxford University Press, 2019-05-01) -
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results
(American Society of Clinical Oncology, 2023-10-20) -
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
(Nature Portfolio, 2023-03-13) -
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer
(American Association for Cancer Research, 2021-11-01) -
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer
(MDPI, 2021-04-17) -
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial
(American Association for Cancer Research, 2021-05-27)